Karen Zaderej Named Chief Operating Officer of AxoGen, Incorporated

Share Article

AxoGen, Inc. announced today the promotion of Karen Zaderej to the newly created position of Chief Operating Officer. The promotion speaks to the growth of AxoGen since the launch of its peripheral nerve repair graft, AVANCE(TM) Nerve Graft, as well as Ms. Zaderej's integral role in the successful operations of the company. Ms. Zaderej was formerly the Vice President of Sales & Marketing for AxoGen.

As the Chief Operating Officer, Ms. Zaderej will continue to bring focus and drive to AxoGen as we proceed into the commercialization phase of the corporation

    "As the Chief Operating Officer, Ms. Zaderej will continue to bring focus and drive to AxoGen as we proceed into the commercialization phase of the corporation," said Jamie Grooms, CEO and co-founder of AxoGen.

Prior to AxoGen, Karen Zaderej had over 19 years of experience in the medical device market. At Johnson & Johnson, she held senior positions in Marketing, Business Development, and R&D as well as ran a manufacturing business. After leaving J&J, she started Zaderej Medical Consulting to assist medical device companies build and execute winning commercialization plans. She has a MBA from the Kellogg Graduate School of Business and a BS in Chemical Engineering from Purdue University.

AxoGen, Inc. based in Alachua, Florida, is a privately held company pioneering the commercialization of peripheral nerve grafting and nerve regeneration technologies. AxoGen is focused in the advancement of peripheral nerve repair by creating a unique combination of patented technologies and a rich pipeline of new products to change the standard of care for patients with injured peripheral nerves.

Visit AxoGen at: http://www.axogeninc.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Monica L. Tarver
Visit website